Recombinant
RabMAb

Recombinant Anti-Firefly Luciferase antibody [EPR17790] (ab185924)

Publishing research using ab185924? Please let us know so that we can cite the reference in this datasheet.

ab185924 has been referenced in 3 publications.

  • Benhabiles H  et al. Optimized approach for the identification of highly efficient correctors of nonsense mutations in human diseases. PLoS One 12:e0187930 (2017). PubMed: 29131862
  • Li D  et al. An Ebola Virus-Like Particle-Based Reporter System Enables Evaluation of Antiviral Drugs In Vivo under Non-Biosafety Level 4 Conditions. J Virol 90:8720-8 (2016). PubMed: 27440895
  • Simonyan H  et al. A synthetic luciferin improves in vivo bioluminescence imaging of gene expression in cardiovascular brain regions. Physiol Genomics 48:762-770 (2016). PubMed: 27614203

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Sign up